AU4995597A - Methods of using sucrose octasulfate to treat or prevent enveloped virus infection - Google Patents

Methods of using sucrose octasulfate to treat or prevent enveloped virus infection

Info

Publication number
AU4995597A
AU4995597A AU49955/97A AU4995597A AU4995597A AU 4995597 A AU4995597 A AU 4995597A AU 49955/97 A AU49955/97 A AU 49955/97A AU 4995597 A AU4995597 A AU 4995597A AU 4995597 A AU4995597 A AU 4995597A
Authority
AU
Australia
Prior art keywords
treat
methods
prevent
virus infection
enveloped virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49955/97A
Inventor
Manuel A Navia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vertex Pharmaceuticals Inc
Original Assignee
Vertex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Inc filed Critical Vertex Pharmaceuticals Inc
Publication of AU4995597A publication Critical patent/AU4995597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU49955/97A 1996-10-23 1997-10-23 Methods of using sucrose octasulfate to treat or prevent enveloped virus infection Abandoned AU4995597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73546096A 1996-10-23 1996-10-23
US08735460 1996-10-23
PCT/US1997/019181 WO1998017282A1 (en) 1996-10-23 1997-10-23 Methods of using sucrose octasulfate to treat or prevent enveloped virus infection

Publications (1)

Publication Number Publication Date
AU4995597A true AU4995597A (en) 1998-05-15

Family

ID=24955900

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49955/97A Abandoned AU4995597A (en) 1996-10-23 1997-10-23 Methods of using sucrose octasulfate to treat or prevent enveloped virus infection

Country Status (2)

Country Link
AU (1) AU4995597A (en)
WO (1) WO1998017282A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001517715A (en) * 1997-09-23 2001-10-09 ダルハウジー、ユニバーシティー Composition for the treatment of herpes and related viral infections, and pharmaceutical formulations containing the composition
DE19841794A1 (en) * 1998-09-12 2000-03-16 Beiersdorf Ag Synergistic, selective antimicrobial preparation useful for treating acne and seborrheic dermatitis or as deodorant contains antiadhesive agent, e.g. ceramide, and antimicrobial agent
DE19841796A1 (en) * 1998-09-12 2000-03-16 Beiersdorf Ag Combinations of antiadhesives (carbohydrates) and microbicides
DE19841795A1 (en) * 1998-09-12 2000-03-16 Beiersdorf Ag Synergistic, selective antimicrobial preparation containing antiadhesive agent, e.g. sterol, and antimicrobial agent, useful e.g. in treating acne or seborrheic dermatitis or as deodorant
AU2012101A (en) * 1999-12-20 2001-07-03 New Pharma Research Sweden Ab Veterinary compositions
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
MXPA05004278A (en) 2002-10-25 2005-10-05 Foamix Ltd Cosmetic and pharmaceutical foam.
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
JP2008239541A (en) * 2007-03-27 2008-10-09 Kanmonkai:Kk Infection prophylactic of fish and shellfish
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776366C (en) 2009-10-02 2017-07-18 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX2017011630A (en) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Compositions and methods for treating rosacea and acne.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01149730A (en) * 1987-12-07 1989-06-12 Osaka Prefecture Retrovirus proliferation inhibitor
DK505488D0 (en) * 1987-12-21 1988-09-09 Bar Shalom Daniel MEDIUM AND USE OF SAME
DK505588D0 (en) * 1988-02-26 1988-09-09 Jesper Hamburger MEDIUM AND USE OF SAME
AU689603B2 (en) * 1994-06-20 1998-04-02 Kurt Berg A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof

Also Published As

Publication number Publication date
WO1998017282A1 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
AU4995597A (en) Methods of using sucrose octasulfate to treat or prevent enveloped virus infection
AU2500097A (en) Compositions containing bacteriophages and methods of using bacteriophages to treat infections
AU3672797A (en) Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides
AU3434393A (en) Targeted virus
AU4813197A (en) Compositions and methods for treating viral infections
AU3378297A (en) Blood treatment system
AU5732198A (en) Use of the ah receptor and ah receptor ligands to treat or prevent the cytopathicity of viral infection
AU2158000A (en) Treatment of hepatitis c virus infections with interleukin-10
GB9709360D0 (en) Methods for the treatment of herpes virus infections
AU5157998A (en) Methods and compositions for treatment of hepatitis c infection
AU8038998A (en) Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
AU636741B2 (en) Treatment of plants for frost protection
AU5758594A (en) Treatment of viral infections
AU2281601A (en) Treatment of viral infections using levovirinTM
AU5102898A (en) Methods of using butyric acid or butyric acid derivatives to protect against hair loss
AU731581C (en) Dry-heat viral inactivation under controlled moisture conditions
AU4602897A (en) Method for treatment of immunodeficiency virus infection
AU5425098A (en) Compounds and methods to treat infectious diseases
AU3530395A (en) Treatment of viral infections
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
AU2243897A (en) Methods of treating or preventing pain or nociception
AU5584996A (en) Method of treatment of sugar plant to improve the sugar content
AU3762397A (en) Treatment and prevention of helicobacter infection
EP0655919A4 (en) Treatment of human viral infections.
AU4915997A (en) Composition and method for topical treatment of active herpesviral infecti ons